Filing Flows

Filing Flows › Hims & Hers Health (HIMS) › Guidance & outlook

Hims & Hers Health (HIMS) guidance and outlook

Hims & Hers Health's 10-Q filed Nov 9, 2026 makes 32 forward-looking statements.

Guidance and outlook

Hims & Hers Health Revenue: guidance against what was reportedHims & Hers Health Revenue: guidance against what was reportedguided rangereported (above / within / below)Q2 2025$545MQ3 2025$599MFY2025$2.3BQ4 2025$618MFY2026Q1 2026$608MQ2 2026$753MQ3 2026$890M
Met or beat 9 of 9 guided periods. Grey: the last range guided before the figures came out; dot: the reported figure.
Hims & Hers Health: what its forward-looking statements are about (10-Q filed 2026-11-09)Hims & Hers Health: what its forward-looking statements are about (10-Q filed 2026-11-09)Other11Demand7Costs7Margins4Products1People1Capital spending1
32 statements; tone +0.16 (−1 all cautious, +1 all confident); 12 hedged.
Hims & Hers Health: outlook statements against the filing beforeHims & Hers Health: outlook statements against the filing beforeConfident9Cautious4

Forward-looking statements, 10-Q filed Nov 9, 2026

Hims & Hers Health's latest quarter

Hims & Hers Health, Q3 2026: revenue $890M (+49% year over year), operating margin -7.4%, net loss $33.0M, operating cash flow $65.4M. The chart follows the revenue to costs, profit and cash.

Questions

What does Hims & Hers Health expect?

We expect this shift to continue as we enhance our membership program described below. Additionally, at the end of March 2026, we launched a membership program for our weight loss offerings in the United States, which we expect to continue to evolve in future reporting periods. We expect to retain a significant majority of revenue from Subscribers who maintain a Subscription for more than two years (sometimes referred to by us as “long-term revenue retention”).

Open the interactive view →

Updated Nov 9, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.